
Rahul Madan
I have around 10 years’ experience in the Pharmaceutical Industry working in different areas of Pharmacovigilance. I am... | Ireland
*50 free lookup(s) per month.
No credit card required.
Rahul Madan’s Emails ra****@iq****.com
Rahul Madan’s Phone Numbers No phone number available.
Social Media
Rahul Madan’s Location Ireland
Rahul Madan’s Expertise I have around 10 years’ experience in the Pharmaceutical Industry working in different areas of Pharmacovigilance. I am currently working as Safety Aggregate Reporting Manager at IQVIA (Ireland). My key responsibilities include writing aggregate reports [Development Safety Update Reports (DSURs), Periodic Safety Update reports(PSURs)/Periodic Benefit Risk Evaluation Reports (PBRERs), Medical Device aggregate reports-IDE reports, Addendum to clinical overviews (ACOs)], writing Risk Management Plans (RMPs), reviewing Labeling deliverables, Health Authority Query responses, Signal Management, Benefit-Risk Management activities including authoring BRM sections, Benefit Risk Assessment reports, Risk Minimization Material development, Implementation and tracking. Previously, I was working with Bayer, Ireland as a PV Country Head Deputy. I supported the PVCH in managing all the PV based activities in Ireland according to the Irish and EU legislation. This included, but not limited to adverse event and device event handling, local safety issue and crisis management, risk management planning, safety reports review and submissions, local support to Product Technical Complaints and counterfeit processes, drafting PV agreements/Safety Data Exchange Agreements (SDEAs). Before working at Bayer, I was working with PAREXEL, writing and coordinating various kinds of aggregate reports. I also have worked in ICSR reporting, narrative writing and signal detection teams. In order to further achieve my professional goals and to enhance my skills on various facets of PV, I pursued Professional Certification in Pharmacoepidemiology and Pharmacovigilance from London School of Hygiene and Tropical Medicine, London, UK. During the course, I was trained by experienced professionals from EMA, MHRA and the industry on various aspects of drug safety and risk-benefit of drug use. I got a chance to expand my knowledge base around the following topics: •International drug safety regulations (ICH, GVP Modules, CIOMS, FDA, MedDRA guidelines) •Signal detection and assessment •Statistical methods for signal detection (PRR, ROR, EBGM, BCPNN/IC methods) •Signal Prioritization (Impact analysis of safety signals) •Risk Management Planning and Pharmacoepidemiology• Vaccine PV •Pharmacoepidemiology •Application of Pharmacoepidemiology in PV •Clinical Trial designs- Experimental and Observational study designs (Randomized Clinical trials, Descriptive studies, Cross-sectional studies, Cohort studies, Case-Control studies and Case Only designs)•Critical Appraisal of Clinical trials
Rahul Madan’s Current Industry Iqvia
Rahul
Madan’s Prior Industry
Bristal Healthcare
|
Parexel
|
Bayer Pharmaceuticals
|
Iqvia
Not the Rahul Madan you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Iqvia
Safety Aggregate Reporting Manager
Sat Aug 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Bayer Pharmaceuticals
Pharmacovigilance Country Head Deputy
Mon Jul 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jul 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Parexel
Pharmacovigilance Analyst
Wed Nov 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Parexel
Pharmacovigilance Scientist
Thu Oct 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Oct 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Bristal Healthcare
Product Manager
Thu Jul 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Aug 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)